Drug Patents owned by Eyepoint Pharms
1. Drug name - DEXYCU KIT
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6960346 | EYEPOINT PHARMS | Vehicles for delivery of biologically active substances |
Jul, 2023
(9 months from now) | |
| US10799642 | EYEPOINT PHARMS | Dose guides for injection syringe |
May, 2032
(9 years from now) | |
| US10028965 | EYEPOINT PHARMS | Use of sustained release dexamethasone in post-cataract surgery inflammation |
May, 2034
(11 years from now) | |
| US10159683 | EYEPOINT PHARMS | Use of sustained release dexamethasone in post-cataract surgery inflammation |
May, 2034
(11 years from now) | |
| US10022502 | EYEPOINT PHARMS | Dose guides for injection syringe |
Jun, 2034
(11 years from now) | |
Drugs and Companies using DEXAMETHASONE ingredient
Treatment: Treatment of postoperative inflammation
Dosage: SUSPENSION;INTRAOCULAR
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 9% | SUSPENSION;INTRAOCULAR | Prescription |
2. Drug name - YUTIQ
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8871241 | EYEPOINT PHARMS | Injectable sustained release delivery devices |
Aug, 2027
(4 years from now) | |
Drugs and Companies using FLUOCINOLONE ACETONIDE ingredient
Treatment: NA
Dosage: IMPLANT;INTRAVITREAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.18MG | IMPLANT;INTRAVITREAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.